McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
VERV holding history
Verve Therapeutics, Inc. in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VERV overviewAll 13F holders of VERVFull Q1 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −75−100.0% | Sold out | Holders |
| Q4 2023 | 75 | $1.05K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 75 | $995 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 75 | $1.41K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 75 | $1.08K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 75 | $1.45K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 75 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 75 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 75 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 75 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 75 | $4.00K | <0.1% | +75 | New | Holders |